Review Article
Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions
Table 2
Preclinical spinal cord injury trials using mesenchymal stromal cells (MSCs).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rat bone marrow MSCs (rBMMSCs); human umbilical cord MSCs (hUCMSCs); basic fibroblast growth factors (bFGF); neurotrophin 3 (NT3); hepatocyte growth factor (HGF); brain derived neurotrophic factor (BDNF); glial cell line derived neurotrophic factor (GDNF). |